Neurological Biomarkers Market Report 2021-26: Size, Growth, Size, Share and Forecast – IMARC Group
According to the latest report by IMARC Group, titled “Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global neurological biomarkers market grew at a CAGR of around 15% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample:
https://www.imarcgroup.com/neurological-biomarkers-market/requestsample
Neurological biomarkers refer to the molecules present in the blood or cerebral spinal fluid (CSF). They aid in the diagnosis of brain disorders and monitor disease progression. Some primary sources of these biomarkers include genetic mutations, metabolite levels, brain imaging, post-translational modifications, changes in protein expression, etc. They detect biological responses to experimental drugs and help in finding new targets for therapeutic intervention. As a result, neurological biomarkers are widely utilized in clinical practice during drug development.
The increasing prevalence of various neurological disorders, including stroke, motor neuron disease, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, etc., is bolstering the demand for faster drug development. This, in turn, is driving the neurological biomarkers market as biomarkers assist in measuring the efficacy of therapeutic strategies and drugs. Moreover, the growing adoption of minimally invasive procedures and the rising use of personalized medicines are further augmenting the growth of the global market. Additionally, the introduction of digital biomarkers, continuous advancements in mass spectrometry, and the elevating number of clinical trials are also anticipated to cater to the market for neurological biomarkers in the coming years.
Neurological Biomarkers Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global neurological biomarkers market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- Acumen Pharmaceuticals Inc.
- Athena Diagnostics (Quest Diagnostics)
- Banyan Biomarkers Inc.
- Bio-Rad Laboratories Inc.
- Immunarray Pvt. Ltd.
- Myriad Rbm Inc. (Myriad Genetics Inc.)
- Proteome Sciences Plc
- Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the global neurological biomarkers market on the basis of type, application, end-use, and region.
Breakup by Type:
- Genomic Biomarkers
- Proteomic Biomarkers
- Metabolomic Biomarkers
- Imaging Biomarkers
- Others
Breakup by Application:
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Autism Spectrum Disorders
Breakup by End-Use:
- Hospital Laboratories
- Clinical Diagnostic Centers
- Research Organizations
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurological-biomarkers-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
